Entourage Health Corp. reaffirmed preliminary unaudited revenue guidance for the fiscal year ended December 31, 2021. For the year, the company expects total revenues to be $54.8 million, an increase of 54% year-over-year, representing a record year of sales growth and expanded market share across its adult-use and medical sales channels.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 CAD | 0.00% |
|
-33.33% | -33.33% |
12/06 | Transcript : Entourage Health Corp. - Shareholder/Analyst Call | |
28/05 | Transcript : Entourage Health Corp., Q1 2024 Earnings Call, May 28, 2024 |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.33% | 22.52L | |
+85.84% | 196.82Cr | |
+300.00% | 5.33Cr |
- Stock Market
- Equities
- ENTG Stock
- News Entourage Health Corp.
- Entourage Health Corp. Reaffirms Preliminary Unaudited Revenue Guidance for the Fiscal Year Ended December 31, 2021